Atalanta Therapeutics
About:
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Website: https://www.atalantatx.com/
Top Investors: F-Prime Capital
Description:
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.
Total Funding Amount:
$110M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2018-01-01
Contact Email:
contact(AT)atalantatx.com
Founders:
Anastasia Khvorova, Craig Mello, Jim Glasheen, Neil Aronin
Number of Employees:
11-50
Last Funding Date:
2021-01-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai